Roger Pamphlett

8.6k total citations
159 papers, 3.4k citations indexed

About

Roger Pamphlett is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Roger Pamphlett has authored 159 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Neurology, 37 papers in Genetics and 36 papers in Molecular Biology. Recurrent topics in Roger Pamphlett's work include Amyotrophic Lateral Sclerosis Research (62 papers), Neurogenetic and Muscular Disorders Research (33 papers) and Heavy Metal Exposure and Toxicity (29 papers). Roger Pamphlett is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (62 papers), Neurogenetic and Muscular Disorders Research (33 papers) and Heavy Metal Exposure and Toxicity (29 papers). Roger Pamphlett collaborates with scholars based in Australia, United States and United Kingdom. Roger Pamphlett's co-authors include Stephen Kum Jew, Bing Yu, Julia M. Morahan, David Bishop, Ronald J. Trent, Philip Doble, Glenda M. Halliday, John G. Morris, Gorm Danscher and Meredin Stoltenberg and has published in prestigious journals such as PLoS ONE, Brain and PEDIATRICS.

In The Last Decade

Roger Pamphlett

154 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Pamphlett Australia 34 1.3k 832 635 504 414 159 3.4k
Jessica Mandrioli Italy 32 1.7k 1.3× 780 0.9× 331 0.5× 749 1.5× 261 0.6× 121 2.9k
Takashi Inuzuka Japan 35 1.5k 1.1× 1.4k 1.7× 359 0.6× 286 0.6× 1.1k 2.6× 194 4.0k
Isao Hozumi Japan 33 1.2k 0.9× 1.4k 1.7× 446 0.7× 256 0.5× 1.1k 2.6× 142 4.1k
Guodong Gao China 35 678 0.5× 1.3k 1.6× 269 0.4× 206 0.4× 573 1.4× 128 3.7k
Andrew King United Kingdom 30 1.7k 1.3× 1.4k 1.7× 127 0.2× 665 1.3× 328 0.8× 75 3.9k
Şermin Genç Türkiye 40 410 0.3× 2.2k 2.6× 449 0.7× 288 0.6× 363 0.9× 99 5.2k
Kürşad Genç Türkiye 32 401 0.3× 1.2k 1.5× 441 0.7× 271 0.5× 309 0.7× 55 4.0k
Xia Qin China 36 382 0.3× 1.9k 2.2× 303 0.5× 247 0.5× 241 0.6× 160 4.4k
Fabio Coppedè Italy 42 584 0.5× 2.9k 3.5× 340 0.5× 158 0.3× 355 0.9× 126 5.5k
Jian Guan New Zealand 40 591 0.5× 1.3k 1.5× 210 0.3× 141 0.3× 694 1.7× 123 4.3k

Countries citing papers authored by Roger Pamphlett

Since Specialization
Citations

This map shows the geographic impact of Roger Pamphlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Pamphlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Pamphlett more than expected).

Fields of papers citing papers by Roger Pamphlett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Pamphlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Pamphlett. The network helps show where Roger Pamphlett may publish in the future.

Co-authorship network of co-authors of Roger Pamphlett

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Pamphlett. A scholar is included among the top collaborators of Roger Pamphlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Pamphlett. Roger Pamphlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henden, Lyndal, Liam G. Fearnley, Dominic B. Rowe, et al.. (2024). Short tandem repeat expansions in LRP12 are absent in cohorts of familial and sporadic amyotrophic lateral sclerosis patients of European ancestry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 25(5-6). 644–647.
2.
Pamphlett, Roger, et al.. (2024). Early life events may be the first steps on the multistep path to amyotrophic lateral sclerosis. Scientific Reports. 14(1). 28497–28497.
3.
Pamphlett, Roger & David Bishop. (2023). The toxic metal hypothesis for neurological disorders. Frontiers in Neurology. 14. 1173779–1173779. 17 indexed citations
4.
Wu, Kathy H. C., et al.. (2023). A mitochondrial cytopathy presenting with persistent troponin elevation: case report. European Heart Journal - Case Reports. 7(4). ytad132–ytad132.
5.
Huang, Sun, Omid Haji‐Ghassemi, Ivana A. Souza, et al.. (2020). A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Cav3.2 T-type channel activity. Molecular Brain. 13(1). 33–33. 18 indexed citations
8.
Pamphlett, Roger, et al.. (2013). Different Occupations Associated with Amyotrophic Lateral Sclerosis: Is Diesel Exhaust the Link?. PLoS ONE. 8(11). e80993–e80993. 25 indexed citations
9.
Pamphlett, Roger, et al.. (2008). A simple method for comparing microarray genotype data between brain and other tissues. Journal of Neuroscience Methods. 173(2). 315–317. 2 indexed citations
10.
Burke, David, et al.. (2006). Riluzole therapy for motor neurone disease: An early Australian experience (1996–2002). Journal of Clinical Neuroscience. 13(1). 78–83. 31 indexed citations
11.
Morahan, Julia M. & Roger Pamphlett. (2006). Amyotrophic Lateral Sclerosis and Exposure to Environmental Toxins: An Australian Case-Control Study. Neuroepidemiology. 27(3). 130–135. 72 indexed citations
12.
Pamphlett, Roger. (2004). Somatic mutation: a cause of sporadic neurodegenerative diseases?. Medical Hypotheses. 62(5). 679–682. 24 indexed citations
13.
Krishnan, Arun V., Roger Pamphlett, David Burke, E. J. Wills, & Matthew C. Kiernan. (2004). Cytoplasmic body myopathy masquerading as motor neuron disease. Muscle & Nerve. 30(5). 667–672. 3 indexed citations
14.
Wilmshurst, Jo M., Chris Rittey, Coleen Adams, et al.. (2001). Severe infantile axonal neuropathy with respiratory failure. Muscle & Nerve. 24(6). 760–768. 23 indexed citations
15.
Poljak, Anne, Roger Pamphlett, Mark E. Gurney, & Mark W. Duncan. (2000). Measurement ofo- andm-tyrosine as markers of oxidative damage in motor neuron disease. Redox Report. 5(2-3). 137–140. 2 indexed citations
16.
Pamphlett, Roger, et al.. (1998). Entry of low doses of mercury vapor into the nervous system.. PubMed. 19(1). 39–47. 34 indexed citations
17.
Sue, Carolyn M., Denis Crimmins, Young Soo, et al.. (1998). Neuroradiological features of six kindreds with MELAS tRNALeu A3243G point mutation: implications for pathogenesis. Journal of Neurology Neurosurgery & Psychiatry. 65(2). 233–240. 96 indexed citations
18.
Ma, Naili, Antony J. Harding, Roger Pamphlett, Geeta Chaudhri, & Nicholas H. Hunt. (1997). Increasedc‐fosExpression in the Brain during Experimental Murine Cerebral Malaria: Possible Association with Neurologic Complications. The Journal of Infectious Diseases. 175(6). 1480–1489. 15 indexed citations
19.
Lamont, Phillipa J., et al.. (1995). Differences in Diaphragm Fiber Types in SIDS Infants. Journal of Neuropathology & Experimental Neurology. 54(1). 32–37. 8 indexed citations
20.
Pamphlett, Roger & John Walsh. (1989). Infective endocarditis with inflammatory lesions in the peripheral nervous system. Acta Neuropathologica. 78(1). 101–104. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026